1. Home
  2. Clinical Topics
  3. FDA approves new drugs
Clinical TopicsDrugs and DevicesNewsOncologyUncategorized

FDA approves new drugs

Share
  • ·On Sept. 22, the U.S. Food and Drug Administration (FDA) approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with advanced colorectal cancer who are no longer responding to other therapies. Read more
  • On Sept. 17, the FDA approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults. Read more

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts